Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments

ESPE Yearbook of Paediatric Endocrinology

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 19 | ESPEYB19 | Next issue

Yearbook of Paediatric Endocrinology 2022

6. DSD and Gender Incongruence

Previous section
Gender Incongruence: Growth and fertility in transgender girls

Table of contents

ey0019.6-14 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments

6.14. Sex hormones drive changes in lipoprotein metabolism

ey0019.6-15 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments

6.15. Self-perception of transgender adolescents after gender-affirming treatment: a follow-up study into young adulthood

ey0019.6-16 | Gender Incongruence: Wider impacts of gender affirming hormone (GAH) treatments

6.16. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more